Term
|
Definition
| Muscarine receptor no medical use, SLUD |
|
|
Term
|
Definition
| M+N, intraocular use for miosis, SLUD |
|
|
Term
|
Definition
| M+N, intraocular use for miosis, glaucoma, SLUD |
|
|
Term
|
Definition
|
|
Term
|
Definition
| M, urinary retention, post operative ileus, SLUD |
|
|
Term
|
Definition
| Partial N agonsist, smoking cessation, SLUD |
|
|
Term
|
Definition
| Rev. AChE inh., Myassthenia Gravis, SLUD |
|
|
Term
|
Definition
| Reversible AChE, myasthenia gravis, glaucoma, post operative ileus, SLUD |
|
|
Term
|
Definition
| Rev. AChE inh., Myasthenia gravis, post op ileus, glaucoma, SLUD |
|
|
Term
|
Definition
| Reversible AChE, glaucoma, AD, antidote to anticholinergic OD, SLUD |
|
|
Term
|
Definition
| Rev. AChE inh., glaucoma, AD, N&V, anorexia, weight loss |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| non-selective M antagonist, mydriatic, sedation, tachycardia, dry mouth |
|
|
Term
|
Definition
| M ant. sea sickness, ANTI SLUD |
|
|
Term
|
Definition
| Non-selective M ant. topically to produce cycloplegia, anti-SLUD |
|
|
Term
|
Definition
| non-selective M ant. GI spasms and peptic ulcers, anti-slud |
|
|
Term
|
Definition
| non-selective M ant. GI spasms and peptic ulcers, anti-SLUD |
|
|
Term
|
Definition
| M in the eyes, mydriasis, anti SLUD |
|
|
Term
|
Definition
| M3 rec ant., asthma of COPD, anti slud |
|
|
Term
|
Definition
| anti-AChE and antihistamine effects, PD, anti-slud |
|
|
Term
|
Definition
|
|
Term
|
Definition
| M ant. urinary incontinence, anti slud |
|
|
Term
|
Definition
| M ant., antispamodic, anti-slud |
|
|
Term
|
Definition
| M ant., antihistamine, anti-slud |
|
|
Term
|
Definition
| M. ant, TCA antidepressant, anti-slud |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Inhibits ACh release, old skin |
|
|
Term
|
Definition
| Inhibits uptake of choline |
|
|
Term
| Trimethaphan camphorsulfonate |
|
Definition
| Ganglionic (nicotinic) blocker, hypertensive crisis |
|
|
Term
|
Definition
| Ganglionic (nicotinic) blocker, hypertensive crisis |
|
|
Term
|
Definition
| Nic. rec block at motor end plate, muscle relaxation during surgery |
|
|
Term
|
Definition
| Nic. rec block at motor end plate, muscle relaxation during surgery |
|
|
Term
|
Definition
| Nic. rec block at motor end plate, muscle relaxation during surgery |
|
|
Term
|
Definition
| Nic. rec block at motor end plate, muscle relaxation during surgery |
|
|
Term
|
Definition
| Nic. rec block at motor end plate, muscle relaxation during surgery |
|
|
Term
|
Definition
| Nic. rec block at motor end plate, muscle relaxation during surgery |
|
|
Term
|
Definition
| Nic. rec block at motor end plate, muscle relaxation during surgery |
|
|
Term
|
Definition
| alpha, b1, b2 agonist, pressor - dec HR |
|
|
Term
|
Definition
| alpha, B1, B2, anaphylaxis, glaucoma, local anestetics (adjunct), inc HR |
|
|
Term
|
Definition
| alpha 1, mydriasis, glaucoma, pressor, nasal decongestant |
|
|
Term
|
Definition
| A1 partial agonist, decongestant |
|
|
Term
|
Definition
| A1 partial agonist, decongestant |
|
|
Term
|
Definition
| A1 partial agonist, decongestant |
|
|
Term
|
Definition
| A2 agonist, HTN, sedation, H20 retention, dry mouth |
|
|
Term
|
Definition
| A2 agonist, HTN, sedation, H20 retention, dry mouth |
|
|
Term
|
Definition
| A2 agonist, HTN, sedation, H20 retention, dry mouth |
|
|
Term
|
Definition
| A2 agonist, HTN, sedation, H20 retention, dry mouth |
|
|
Term
|
Definition
| A2 agonist, glaucoma, sedation, H20 retention, dry mouth |
|
|
Term
|
Definition
| A2 agonist, muscle spasticity, sedation, H20 retention, dry mouth |
|
|
Term
|
Definition
| non-selective beta agonist, asthma, COPD, cardiostimulant - inc HR |
|
|
Term
|
Definition
| B1 receptor, critical life threatening situations |
|
|
Term
|
Definition
| B2 agonist, asthma, COPD, tocolytic |
|
|
Term
|
Definition
| B2 agonist, asthma, COPD, tachycardia |
|
|
Term
|
Definition
| B2 agonist, asthma, COPD, tachycardia |
|
|
Term
|
Definition
| B2 agonist, asthma, COPD, tachycardia |
|
|
Term
|
Definition
| B2 agonist, asthma, COPD, tachycardia |
|
|
Term
|
Definition
|
|
Term
|
Definition
| B1 agonist, acute heart failure, shock; + inotropic effect |
|
|
Term
|
Definition
| NET reverser, ADHD, narcolepsy |
|
|
Term
|
Definition
| Direct acting agonist, nasal decongestant, CTN: HTN |
|
|
Term
|
Definition
| NET reverser, nasal decongestant, CTN: HTN |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Transport blocker, depression, ADD |
|
|
Term
|
Definition
|
|
Term
|
Definition
| MAO inh. early PD, depression |
|
|
Term
|
Definition
| A1, A2 ant. pheochromocytoma, HTN crisis, orthostatic hypotension, tachycardia |
|
|
Term
|
Definition
| A1, A2 ant. phenochromocytoma, HTN crisis, impotence, orthostatic hypotension, tachycardia |
|
|
Term
|
Definition
| A1 ant. HTN and BPH, reflex tachycardia and orthostatic hypotension |
|
|
Term
|
Definition
| A1 ant. HTN and BPH, reflex tachycardia and orthostatic hypotension |
|
|
Term
|
Definition
| A1 ant. HTN and BPH, reflex tachycardia and orthostatic hypotension |
|
|
Term
|
Definition
| A1, A2 ant, migraines, LSD effect |
|
|
Term
|
Definition
|
|
Term
|
Definition
| B1, B2 ant. HTN, angina, migraine, glaucoma, CHF; bradycardia, AV block; CTN: asthma, COPD |
|
|
Term
|
Definition
| B1, B2 ant. HTN, angina, migraine, glaucoma, CHF; bradycardia, AV block; CTN: asthma, COPD |
|
|
Term
|
Definition
| B1, B2 ant. HTN, angina, migraine, glaucoma, CHF; bradycardia, AV block; CTN: asthma, COPD |
|
|
Term
|
Definition
| B1, B2 ant. HTN, angina, migraine, glaucoma, CHF; bradycardia, AV block; CTN: asthma, COPD |
|
|
Term
|
Definition
| B1, B2 ant. HTN, angina, migraine, glaucoma, CHF; bradycardia, AV block; CTN: asthma, COPD |
|
|
Term
|
Definition
| B1 ant., HTN, angina, CHF, bradycardia, AV block, sedation CTN: asthma, COPD |
|
|
Term
|
Definition
| B1 ant., HTN, angina; bradycardia, AV block, sedation CTN: asthma, COPD |
|
|
Term
|
Definition
| B1 ant., HTN, angina; bradycardia, AV block, sedation CTN: asthma, COPD |
|
|
Term
|
Definition
| B1 ant., HTN, angina; bradycardia, AV block, sedation CTN: asthma, COPD |
|
|
Term
|
Definition
| B1 B2 A1 ant. HTN and HTN crisis, B-blocking prevents reflex tachycardia from A1 block |
|
|
Term
|
Definition
| B1, B2, A1 ant. HTN and CHF, B-blocking blocks reflex tach. from A block |
|
|
Term
|
Definition
| Inh. NE synthesis, pheochromocytoma, EPS, orthostatic hypotension |
|
|
Term
|
Definition
| deplete vesicular stores of NE, HTN, may be linked to depression |
|
|
Term
|
Definition
| NE release inhibitor, antiarrhythmic, CTN: pts with AV block |
|
|
Term
|
Definition
| DA, NE, 5-HT releasing agent, decongestant |
|
|
Term
|
Definition
|
|
Term
|
Definition
| DA, NE, 5-HT releaser, ADHD |
|
|
Term
|
Definition
| DA/NE reuptake inh., ADHD |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| NET blocker - appetite suppression |
|
|
Term
|
Definition
| DAT/NET blocker, appetite suppression |
|
|
Term
|
Definition
| DAT/NET blocker, appetite suppression |
|
|
Term
|
Definition
| DAT/NET blocker, appetite suppression |
|
|
Term
|
Definition
| SERT/NET inh. appetite suppressant |
|
|
Term
|
Definition
|
|
Term
| Sinemet (levadopa/carbidopa) |
|
Definition
| PD, inhibits decarboxylase in periphery |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Chloropromazine (Thorazine) |
|
Definition
| A1 and 5HT ag. 1st gen antipsychotic, EPS |
|
|
Term
|
Definition
| H1 ant. 1st gen antipsychotic |
|
|
Term
|
Definition
| D2 ant. 1st gen antipsychotic |
|
|
Term
|
Definition
| D2 ant. 1st gen antipsychotic, EPS |
|
|
Term
|
Definition
| D2 ant. 1st gen antipsychotic, EPS |
|
|
Term
|
Definition
| D2 ant. 1st gen antipsychotic, EPS |
|
|
Term
|
Definition
| D2 ant. 1st gen antipsychotic, EPS |
|
|
Term
|
Definition
| D2 ant. 1st gen antipsychotic, EPS |
|
|
Term
|
Definition
| D2 ant. 1st gen antipsychotic, EPS |
|
|
Term
|
Definition
| D2 ant. 1st gen antipsychotic, EPS |
|
|
Term
|
Definition
| 5-HT2A>D2, atypical antipsychotic, less EPS, treats secondary symptoms |
|
|
Term
|
Definition
| 5-HT2A>D2, atypical antipsychotic, less EPS, treats secondary symptoms |
|
|
Term
|
Definition
| 5-HT2A>D2, atypical antipsychotic, less EPS, treats secondary symptoms |
|
|
Term
|
Definition
| 5-HT2A>D2, atypical antipsychotic, less EPS, treats secondary symptoms |
|
|
Term
|
Definition
| 5-HT2A>D2, atypical antipsychotic, less EPS, treats secondary symptoms |
|
|
Term
|
Definition
| 5HT, D2, A1 ant. atypical antipsychotic, less EPS, treats secondary symptoms |
|
|
Term
|
Definition
| 5HT2 and D2 partial agonist, antipyschotic |
|
|
Term
|
Definition
| non-selective MAOI, antidepressant |
|
|
Term
|
Definition
| non-selective MAOI, antidepressant |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| TCA - NET and SERT inh. antidepressant, can OD - tertiary amine |
|
|
Term
|
Definition
| TCA - NET and SERT inh. antidepressant, can OD - tertiary amine |
|
|
Term
|
Definition
| TCA - NET and SERT inh. antidepressant, can OD - tertiary amine |
|
|
Term
|
Definition
| TCA - NET and SERT inh. antidepressant, can OD - tertiary amine |
|
|
Term
|
Definition
| TCA - NET and SERT inh. antidepressant, can OD - tertiary amine |
|
|
Term
|
Definition
| TCA - NET and SERT inh. antidepressant, can OD - secondary amine |
|
|
Term
|
Definition
| secondary TCA - NET/SERT inh. can OD |
|
|
Term
|
Definition
| secondary TCA - NET/SERT inh. can OD |
|
|
Term
|
Definition
| secondary TCA - NET/SERT inh. can OD |
|
|
Term
|
Definition
| SSRI - depression, OCD, PTSD |
|
|
Term
|
Definition
| SSRI - depression, OCD, PTSD |
|
|
Term
|
Definition
| SSRI - depression, OCD, PTSD |
|
|
Term
|
Definition
| SSRI - depression, OCD, PTSD |
|
|
Term
|
Definition
| SSRI - depression, OCD, PTSD |
|
|
Term
|
Definition
| SSRI - depression, OCD, PTSD |
|
|
Term
|
Definition
| D2 ant, NET inh. anitdepressant |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 5HT2A ant. antidepressant |
|
|
Term
|
Definition
| DAT>NET=SERT inh. antidepressant |
|
|
Term
|
Definition
| A2 ant, 5HT2, 5HT3, H1, ant. antidepressant |
|
|
Term
|
Definition
| NET and SERT inh. SNRI, GAD, panic, depression |
|
|
Term
|
Definition
| NET/SERT inh. SNIR; GAD, depression |
|
|
Term
|
Definition
| NET inh. Depression, ADHD |
|
|
Term
|
Definition
| NET inh. antidepressant, ADHD |
|
|
Term
|
Definition
| BZD; muscle spasms, sedation |
|
|
Term
|
Definition
| GABA-B ag. activates K+ channels, muscle relaxant |
|
|
Term
|
Definition
| A2 ag. works in reflex arc, muscle relaxant |
|
|
Term
|
Definition
| Acute muscle spasm, anitmuscarinic properties |
|
|
Term
|
Definition
| Reduces release of Ca++ from SR, cerebral palsy, MS, malignant hyperthermia |
|
|
Term
|
Definition
| AChE, Neuromuscular blocks |
|
|
Term
|
Definition
| AChE, Neuromuscular blocks |
|
|
Term
|
Definition
| AChE, Neuromuscular blocks |
|
|
Term
|
Definition
| AChE, Neuromuscular blocks |
|
|
Term
|
Definition
| AChE, Neuromuscular blocks |
|
|
Term
|
Definition
| AChE, Neuromuscular blocks |
|
|
Term
|
Definition
| Activate K+, block Na+, disrupt membrane potential; inhaled anesthetics, malignant hyperthermia |
|
|
Term
|
Definition
| Activate K+, block Na+, disrupt membrane potential; inhaled anesthetics, malignant hyperthermia, FAST |
|
|
Term
|
Definition
| Activate K+, block Na+, disrupt membrane potential; inhaled anesthetics, malignant hyperthermia |
|
|
Term
|
Definition
| Activate K+, block Na+, disrupt membrane potential; inhaled anesthetics, malignant hyperthermia |
|
|
Term
|
Definition
| Activate K+, block Na+, disrupt membrane potential; inhaled anesthetics, malignant hyperthermia |
|
|
Term
|
Definition
| Block NDMA rec. dissociative anesthesia |
|
|
Term
|
Definition
|
|
Term
|
Definition
| GABA channels, rapid onset/recovery |
|
|
Term
|
Definition
| Local anesthetic (blocks activated and inactivated Na+ channels) |
|
|
Term
|
Definition
| Local anesthetic (blocks activated and inactivated Na+ channels) |
|
|
Term
|
Definition
| Local anesthetic (blocks activated and inactivated Na+ channels) |
|
|
Term
|
Definition
| Local anesthetic (blocks activated and inactivated Na+ channels) |
|
|
Term
|
Definition
| Local anesthetic (blocks activated and inactivated Na+ channels) |
|
|
Term
|
Definition
| Local anesthetic (blocks activated and inactivated Na+ channels) |
|
|
Term
|
Definition
| BZD, metabolites, anxiolytic |
|
|
Term
|
Definition
| BZD, metabolites, anxiolytic |
|
|
Term
|
Definition
| BZD, hypnotic, metabolites |
|
|
Term
|
Definition
| BZD, metabolites, anxiolytic |
|
|
Term
|
Definition
| BZD, hypnotic, metabolites |
|
|
Term
|
Definition
| BZD, anxiolytic and anesthetic |
|
|
Term
|
Definition
| BZD, metabolites, hypnotic |
|
|
Term
|
Definition
|
|
Term
|
Definition
| BZD, anxiolytic, EtOH withdrawal |
|
|
Term
|
Definition
| BZD, anxiolytic, EtOH withdrawal |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Z-drug, insomnia, bind A1 subunit of BZ1 site |
|
|
Term
|
Definition
| Z-drug, insomnia, bind A1 subunit of BZ1 site |
|
|
Term
|
Definition
| Z-drug, insomnia, bind A1 subunit of BZ1 site |
|
|
Term
|
Definition
| Barbiturate, anticonvulsant |
|
|
Term
|
Definition
| Barbiturate, anticonvulsant |
|
|
Term
|
Definition
| Barbiturate, sedative-hypnotic |
|
|
Term
|
Definition
| Barbiturate, sedative-hypnotic |
|
|
Term
|
Definition
| Barbiturate, sedative-hypnotic |
|
|
Term
|
Definition
| Barbiturate, sedative-hypnotic |
|
|
Term
|
Definition
| Barbiturate, sedative-hypnotic |
|
|
Term
|
Definition
| Barbiturate, IV anesthetic |
|
|
Term
|
Definition
| Barbiturate, IV anesthetic |
|
|
Term
|
Definition
| Barbiturate, IV anesthetic |
|
|
Term
|
Definition
| MT1 and MT2 ag. works on circardian cycles, sleep |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Partial 5HT1A ag. GAD, socail anxiety |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Na+ blocker, partial/tonic clonic |
|
|
Term
|
Definition
| Na+ blocker, partial/tonic-clonic |
|
|
Term
|
Definition
| All Sz's except absense, Na+ blocker |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Partial, inc. GABA and Ca++ blocker |
|
|
Term
|
Definition
| Neuropathic pain, increase GABA |
|
|
Term
|
Definition
| Adjunct for refractory Sz's, Irr inh. of GABA transaminase |
|
|
Term
|
Definition
| Partial/tonic-clonic, Inh. GAT-1 |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Partial and Lennox-Gastaut syndrome |
|
|
Term
|
Definition
| Partial, Na+ channel blocker |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Partial/tonic-clonic, AMAP ant. |
|
|
Term
|
Definition
| Absence, T-type Ca++ blocker |
|
|
Term
|
Definition
| Absense, partial, generalized, bipolar; Na+, Ca++, GABA |
|
|
Term
|
Definition
| Tonic/clonic, absence, Na+ |
|
|
Term
|
Definition
| Weak analgesic, good antitussive |
|
|
Term
|
Definition
| Sever, acute, chronic pain |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| good antitussive no analgesic |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Mild/moderate pain, weak Mu agonist |
|
|
Term
|
Definition
| Pain and addiction, Mu ag |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Pain, increases theshold and creates amnesia |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Severe pain, selective Mu agonist |
|
|
Term
| Diphenoxylate with atropine (Lomotil) |
|
Definition
| Diarrhea, Mu and Delta ant |
|
|
Term
| Difenoxin with atropine (Motofen) |
|
Definition
| Diarrhea, Mu and delta ant |
|
|
Term
|
Definition
| diarrhea, Mu and delta ant |
|
|
Term
| Buprenophine (Buprenex, Subutex) |
|
Definition
| Opioid withdrawal, partial Mu agonist, weak kappa ag and delta ant |
|
|
Term
|
Definition
| Moderate to severe pain, strong kappa agonist, partial mu agonist |
|
|
Term
|
Definition
| Mod/severe pain K ag mu ant |
|
|
Term
|
Definition
| mild/mod pain; kappa ag partial mu ag |
|
|
Term
|
Definition
| severe pain, parial mu agonist |
|
|
Term
| Pentazocine with naloxone |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Heroin addiction and EtOH dependence, opioid receptor ant |
|
|
Term
|
Definition
| Alcohol dependence, opioid receptor ant |
|
|
Term
|
Definition
| Methanol/ethylene glycol poisoning |
|
|
Term
|
Definition
| Aldehyde dehydrogenase inh. alcoholism |
|
|
Term
|
Definition
| NMDA ant. reduced withdrawal from EtOH |
|
|